Chief R&D Officer of FATE THERAPEUTICS INC (U.S.: Nasdaq:FATE), Valamehr Bahram, sells 5,596 shares worth $259,558
According to FATE THERAPEUTICS INC's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief R&D Officer, Valamehr Bahram disclosed selling 5,596 shares at a cost of $46.38. At the time of this transaction (Jan 10), this trade was worth $259,558 in total. As of Jan 10, Valamehr Bahram now owns 151,102 shares in total worth about $6,504,941.1.
For the last few recent trades made by FATE THERAPEUTICS INC (U.S.: Nasdaq:FATE) Chief R&D Officer, Valamehr Bahram, we have the following information:
- SEC Form 4 filing: Dec 13: Sold 25,000 shares at the rate of $47.66 per share. Total worth of this trade was $1,191,406. Total number of shares owned as of Dec 13 were 156,698
- SEC Form 4 filing: Sep 13: Sold 25,000 shares at the rate of $66.29 per share. Total worth of this trade was $1,657,257. Total number of shares owned as of Sep 13 were 95,740
- SEC Form 4 filing: Jun 14: Sold 25,000 shares at the rate of $89.32 per share. Total worth of this trade was $2,233,045. Total number of shares owned as of Jun 14 were 95,740
Posted by
George Daniels
on Thursday January 13 2022, 1:30 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
